Match tier
Listed
Presence
Current · Arkansas
Last published
2023
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
M
Md Shadiqul Hoque
Researcher
Also affiliated: Winthrop Rockefeller Foundation (2020–2021)
Unknown Researcher
College of Medicine Administration
2 h-index
4 pubs
5 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Md Shadiqul Hoque's research focuses on healthcare quality improvement and the application of advanced medical imaging techniques for disease prognostication. He has contributed to studies investigating the prediction of disease progression in relapsed multiple myeloma, utilizing traditional risk models alongside PET-CT imaging and minimal residual disease status. Hoque also participated in the "RQUEST" committee, an institutional initiative aimed at enhancing quality improvement education and project implementation for hematology/oncology fellows.
His work involves collaborations with researchers at the University of Arkansas for Medical Sciences, including Jim Zhongning Chen, Alan Baltz, Sajjad Akbar Bhatti, and Troy Schmit. Hoque's scholarly output includes four publications with an h-index of 2 and 5 total citations. He remains an active researcher, with his most recent publication in 2023.
Metrics
- h-index: 2
- Publications: 4
- Citations: 5
Selected Publications
-
In vivo CAR T-cell engineering in B-cell malignancies: A systematic review of emerging clinical and translational evidence. (2026)
-
Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows. (2023)
-
Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission (2022)
-
Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance (2021)
-
Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma (2021)
-
Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status (2021)
-
Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM). (2021)
-
Late Relapsing Multiple Myeloma ≥ 10 Years after Treatment on Total Therapy Protocols Are Associated with Good Outcome (2020)
-
Predicting Risk of Progression in Relapsed Multiple Myeloma Using Minimal Residual Disease Status and Focal Lesion Assessment with PET-CT (2020)
-
Feasibility of Outpatient Autologous Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predicting Hospital Admission (2020)
-
Nivolumab for Treatment of Advanced, Refractory, High-Risk Multiple Myeloma (2017)
-
Clinical and Molecular Characterization of Primary Plasma Cell Leukemia (2017)
-
Characteristics and Surgical Success of Patients Presenting for Repair of Genitourinary Fistula in VVF Center of a Tertiary Hospital (2017)
-
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype (2017)
-
Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease (2017)
Collaboration Network
Top Collaborators
Sravani Gundarlapalli
University of Arkansas for Medical Sciences
5 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Sharmilan Thanendrarajan
University of Arkansas for Medical Sciences
5 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Maurizio Zangari
University of Arkansas for Medical Sciences
5 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Frits van Rhee
University of Arkansas for Medical Sciences
5 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Guido Tricot
University of Arkansas for Medical Sciences
5 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Carolina Schinke
University of Arkansas for Medical Sciences
5 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Lakshmi Yarlagadda
University of Arkansas for Medical Sciences (US)
4 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Richa Parikh
University of Arkansas for Medical Sciences (US)
4 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Mathew Kottarathara
University of Arkansas for Medical Sciences (US)
4 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Yetunde Ogunsesan
University of Arkansas for Medical Sciences (US)
4 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Angel Mitma
University of Arkansas for Medical Sciences (US)
4 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
Meera Mohan
Froedtert Hospital (US)
4 shared publications
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Clyde Bailey
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Kerri Hill
University of Arkansas for Medical Sciences
3 shared publications
In database
- Salvage Autologous Stem Cell Transplantation in Daratumumab-Refractory Multiple Myeloma
- Feasibility of Outpatient Stem Cell Transplantation in Multiple Myeloma and Risk Factors Predictive of Hospital Admission
- Salvage autologous stem cell transplantation in daratumumab refractory multiple myeloma (MM).
Daisy Alapat
2 shared publications
In database
- Predicting risk of progression in relapsed multiple myeloma using traditional risk models, focal lesion assessment with PET-CT and minimal residual disease status
- Eight-Color Flow Cytometry Phenotypic Markers and Disease Progression in Monoclonal Gammopathy of Unknown Significance
Similar Researchers
Based on overlapping research topics
Maryalice Kelly
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Interprofessional Education and Collaboration
Health and Medical Research Impacts
Jennifer Green
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Health and Medical Research Impacts
Public Health Research
Emily Biben
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Health and Medical Research Impacts
Public Health Research
Lauren Havens
University of Arkansas for Medical Sciences
Health Sciences Research and Education
Health and Medical Research Impacts
Public Health Research
H.A. Taha
University of Arkansas at Fayetteville
Health Sciences Research and Education
Health and Medical Research Impacts
Public Health Research
Catherine Harrison
University of Arkansas at Fayetteville
Health Sciences Research and Education
Health and Medical Research Impacts
Public Health Research